|
|
||||||||
REVIEW |
Center for Vitamins and Cancer Research, Department of Radiology, School of Medicine, University of Colorado Health Sciences Center, Denver, Colorado (K.N.P., W.C.C.)Department of Pathology, University of San Francisco School of Medicine, San Francisco, California (K.C.P.)
Department of Pathology, University of San Francisco School of Medicine, San Francisco, California (K.C.P.)
Address reprint requests to: Kedar N. Prasad, Ph.D., Campus Box C-278, UCHSC, 4200 E. 9th Ave., Denver, Colorado, 80262. E-mail: Kedar.Prasad{at}UCHSC.edu
The etiology of Alzheimers disease (AD) is not well understood. Etiologic factors, chronic inflammatory reactions, oxidative and nitrosylative stresses and high cholesterol levels are thought to be important for initiating and promoting neurodegenerative changes commonly found in AD brains. Even in familial AD, oxidative stress plays an important role in the early onset of the disease. Mitochondrial damage and proteasome inhibition represent early events in the pathogenesis of AD, whereas increased processing of amyloid precursor protein (APP) to ß-amyloid (Aß) fragments (Aß40 and Aß42) and formation of senile plaques and neurofibrillary tangles (NFTs) represent late events. We propose a hypothesis that in idiopathic AD, epigenetic components of neurons such as mitochondria, proteasomes and post-translation protein modifications (processing of amyloid precursor protein to ß-amyloid and hyperphosphorylation of tau), rather than nuclear genes, are the primary targets for the action of diverse groups of neurotoxins. Based on epidemiologic, laboratory and limited clinical studies, we propose that a combination of non steroidal anti-inflammatory drugs (NSAIDs) and appropriate levels and types of multiple micronutrients, including antioxidants, may be more effective than the individual agents in the prevention, and they, in combination with a cholinergic agent, may be more effective in the treatment of AD than the individual agents alone. In addition, agents, which can prevent formation of plaques or dissolve these plaques may further enhance the efficacy of our proposed treatment strategy.
Key words: Alzheimers disease, antioxidants, inflammatory reactions, ß-amyloid, cholesterol synthesis, oxidative stress, cholinergic agents
This article has been cited by other articles:
![]() |
D.-M. Chen, L. Xiao, X. Cai, R. Zeng, and X.-Z. Zhu Involvement of Multitargets in Paeoniflorin-Induced Preconditioning J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 165 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G Fillenbaum, M. N Kuchibhatla, J. T Hanlon, M. B Artz, C. F Pieper, K. E Schmader, M. W Dysken, and S. L Gray Dementia and Alzheimer's Disease in Community-Dwelling Elders Taking Vitamin C and/or Vitamin E Ann. Pharmacother., December 1, 2005; 39(12): 2009 - 2014. [Abstract] [Full Text] [PDF] |
||||
![]() |
K N Prasad Rationale for using multiple antioxidants in protecting humans against low doses of ionizing radiation Br. J. Radiol., June 1, 2005; 78(930): 485 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
K N Prasad, W C Cole, and G M Haase Radiation protection in humans: extending the concept of as low as reasonably achievable (ALARA) from dose to biological damage Br. J. Radiol., February 1, 2004; 77(914): 97 - 99. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |